Correction to: Serum fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus | |
Ning H.; Tao H.; Weng Z.; Zhao X. | |
刊名 | Acta Diabetologica |
2018 | |
DOI | 10.1007/s00592-018-1177-0 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4567241 |
专题 | 山东大学 |
作者单位 | Department of Obstetrics and Gynaecology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250012, China, De |
推荐引用方式 GB/T 7714 | Ning H.,Tao H.,Weng Z.,et al. Correction to: Serum fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus[J]. Acta Diabetologica,2018. |
APA | Ning H.,Tao H.,Weng Z.,&Zhao X..(2018).Correction to: Serum fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus.Acta Diabetologica. |
MLA | Ning H.,et al."Correction to: Serum fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus".Acta Diabetologica (2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论